Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa
Br J Dermatol
Epub 2019 Sep 17.
J R Ingram
G B E Jemec
H B Naik
M J Hyde
M A Lowes
Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN, U.S.A.
Departments of Medicine and Dermatology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, U.S.A.
Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, U.K.
Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
Department of Dermatology, University of Copenhagen, Copenhagen, Denmark.
Department of Dermatology, University of California San Francisco, San Francisco, CA, U.S.A.
Department of Medicine, Division of Dermatology, Women's College Hospital, University of Toronto, Toronto, ON, Canada.
The Rockefeller University, New York, NY, U.S.A.
Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, U.S.A.
No abstract available
Hidradenitis Suppurativa* / diagnosis
Severity of Illness Index
Grants and funding
UL1 TR002494/TR/NCATS NIH HHS/United States